We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAQ.U
3726
DELISTED
Athena Consumer Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one Redeemable Warrant
ACAQ.U
$17K ﹤0.01%
1,668
-350
-17% -$3.54K
RTL
3727
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$17K ﹤0.01%
2,152
-489
-19% -$3.96K
CPUH.U
3728
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$17K ﹤0.01%
1,701
+916
+117% +$9.05K
FNCH
3729
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$17K ﹤0.01%
111
+62
+127% +$14.3K
TIG
3730
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$17K ﹤0.01%
3,606
+1,781
+98% +$12K
MSAC
3731
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$17K ﹤0.01%
1,730
+613
+55% +$5.96K
EMCF
3732
DELISTED
Emclaire Financial Corp
EMCF
$17K ﹤0.01%
451
-176
-28% -$5.17K
EDNC
3733
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
$17K ﹤0.01%
1,708
+1,686
+7,664% +$16.5K
EXTN
3734
DELISTED
Exterran Corporation
EXTN
$17K ﹤0.01%
+2,802
New +$14.9K
MUDS
3735
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$17K ﹤0.01%
1,659
-653
-28% -$6.52K
RVI
3736
DELISTED
Retail Value Inc. Common Shares
RVI
$17K ﹤0.01%
5,449
-36,726
-87% -$116K
ADUS icon
3737
Addus HomeCare
ADUS
$2.17B
$16K ﹤0.01%
174
AGX icon
3738
Argan
AGX
$8.11B
$16K ﹤0.01%
396
-80
-17% -$3.13K
ANIX icon
3739
Anixa Biosciences
ANIX
$108M
$16K ﹤0.01%
5,983
+3,060
+105% +$8.98K
ARQT icon
3740
Arcutis Biotherapeutics
ARQT
$3.29B
$16K ﹤0.01%
859
-940
-52% -$15.9K
ASTE icon
3741
Astec Industries
ASTE
$997M
$16K ﹤0.01%
375
-73
-16% -$4.05K
AWR icon
3742
American States Water
AWR
$3.53B
$16K ﹤0.01%
179
-241
-57% -$21.5K
BSM icon
3743
Black Stone Minerals
BSM
$3.05B
$16K ﹤0.01%
1,203
-18,782
-94% -$224K
CUE icon
3744
Cue Biopharma
CUE
$144M
$16K ﹤0.01%
109
+30
+38% +$6.36K
ENVA icon
3745
Enova International
ENVA
$6.61B
$16K ﹤0.01%
411
-60
-13% -$2.41K
EWS icon
3746
iShares MSCI Singapore ETF
EWS
$1.17B
$16K ﹤0.01%
+776
New +$16.3K
FGNX
3747
FG Nexus Inc
FGNX
$40.8M
$16K ﹤0.01%
25
+24
+2,400% +$9.65K
FLXS icon
3748
Flexsteel Industries
FLXS
$301M
$16K ﹤0.01%
838
+328
+64% +$7.5K
FRO icon
3749
Frontline
FRO
$9.17B
$16K ﹤0.01%
1,771
-2,060
-54% -$16.3K
FULC icon
3750
Fulcrum Therapeutics
FULC
$285M
$16K ﹤0.01%
664
-2,963
-82% -$41.9K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.